Specialty

Image description

Imbruvica gets expanded approval from FDA

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

Image description

FDA grants approval to Ruconest

The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.

Image description

Diplomat acquires MedPro Rx

Diplomat announced it has acquired MedPro Rx, a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin.

 

Image description

Report: Patients facing growing challenges accessing orphan drugs

Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.